Can Creatine Boost Therapy for Depression? New Study Says Maybe!

A recent 8-week double-blind, randomized, placebo-controlled trial investigated whether oral creatine monohydrate (5g/day) could enhance the effects of cognitive-behavioral therapy (CBT) in treating major depressive disorder (MDD)—especially in under-resourced areas where access to treatment is limited.

🔬 Why Does This Matter?
While CBT is a gold-standard therapy for depression, many patients do not achieve full remission. This study explored whether creatine—widely used for muscle and brain energy metabolism—could provide an extra boost to treatment.

🧠 Key Findings:
✅ Participants receiving creatine + CBT had greater reductions in depression symptoms (measured by the Hamilton Depression Rating Scale) compared to those receiving placebo + CBT
✅ Reported improvements in mood, energy levels, and cognitive function
✅ Creatine was well-tolerated, with no significant safety concerns
✅ CBT was delivered once weekly by trained therapists

⚠️ Study Limitations:
🔹 Small sample size—larger studies are needed to confirm these findings
🔹 Short trial duration—long-term effects are still unknown
🔹 Study population—results may not generalize to all individuals with MDD

💡 What’s Next?
If larger studies confirm these results, creatine could become an accessible, affordable adjunct to therapy, particularly in communities with limited mental health resources.

What do you think? Could a common fitness supplement help improve mental health? Let’s discuss! ⬇️

link to study: https://www.sciencedirect.com/science/article/pii/S0924977X24007405

Managing Mild to Severe Depression: A Guide to Treatment Approaches

It is crucial to recognize that none of the available medications or neuromodulation procedures, including electroconvulsive therapy (ECT) and psychedelics, are disease-modifying. This means that while these treatments can alleviate symptoms, they do not address the underlying causes of depression. Think of them like acetaminophen for a fever—it may temporarily reduce the fever, but without treating the underlying infection, the fever will return.

Neuromodulation refers to techniques that alter brain activity through electrical or magnetic stimulation. Examples include ECT, transcranial magnetic stimulation (TMS), and vagus nerve stimulation (VNS), all of which have been explored as treatments for severe depression.

Optimizing Depression Treatment for Different Severity Levels

Given this understanding, how can we best utilize these treatments to support patients during difficult times? The key is to acknowledge that medications and neuromodulation primarily serve as symptom management tools, most effectively used in the short term for severe cases.

Mild to Moderate Depression: Prioritizing Non-Medication Approaches

For individuals experiencing mild to moderate depression, medication should not be the first line of treFor individuals experiencing mild to moderate depression, medication should not be the first line of treatment. Many people can directly link their depressive symptoms to stressful life events. In such cases, the best initial approach includes:

  • Cognitive Behavioral Therapy (CBT) – Evidence-based therapy that helps reframe negative thinking patterns. Research has shown that CBT is as effective as antidepressants for mild to moderate depression, with relapse rates significantly reduced in those who complete therapy.
  • Lifestyle Modifications – Regular exercise and a healthy diet have strong evidence supporting their role in reducing depressive symptoms. A study published in JAMA Psychiatry found that individuals engaging in at least 150 minutes of moderate exercise per week had a 25% lower risk of developing depression.

For some, these interventions alone may be sufficient to overcome depression and maintain long-term well-being. If additional support is needed, natural supplements with reasonable evidence, such as St. John’s Wort and S-Adenosylmethionine (SAMe), may be considered for mild to moderate depression. However, these supplements are not without risks—St. John’s Wort can interact with many medications, including antidepressants and birth control pills, potentially reducing their effectiveness. SAMe may cause gastrointestinal discomfort or manic symptoms in individuals with bipolar disorder.

Severe Depression: When Medication and Neuromodulation Play a Role

For individuals with severe depression, particularly those at risk for self-harm or suicide, the risks and benefits of medication should be carefully weighed. Antidepressants and neuromodulation therapies have demonstrated the most significant impact in these cases. When selecting a medication, I prioritize those with a lower risk of concerning side effects, particularly sexual dysfunction. My initial choices often include:

  • Bupropion – A dopamine-norepinephrine reuptake inhibitor with a favorable side effect profile.
  • Vortioxetine – Known for its cognitive benefits and relatively low sexual side effects.
  • Mirtazapine – Can be beneficial for those with sleep disturbances or appetite loss.
  • Vilazodone – A serotonin modulator with a lower incidence of sexual dysfunction compared to SSRIs.

It is essential for patients starting antidepressants to be closely monitored, especially in the early weeks of treatment, to assess for side effects and response. Regular follow-ups with a healthcare provider can help adjust dosages or explore alternative treatments if needed.

Treatment Duration and Discontinuation Considerations

For those starting medication, I generally recommend continuing treatment for 6 to 12 months, followed by an assessment to determine whether tapering off is feasible. This process involves shared decision-making, considering:

  • Symptom severity and stability
  • Level of daily functioning
  • Patient’s goals and preferences

The goal is to ensure that the patient has developed effective coping strategies, engaged in therapy, and adopted a healthy lifestyle before considering medication discontinuation. If stopping medication is not advisable, we work to identify the lowest effective dose for long-term maintenance.

Final Thoughts

Depression treatment should be personalized and dynamic, evolving with the patient’s needs. By recognizing that medications and neuromodulation are tools for symptom management rather than cures, we can ensure they are used effectively—providing relief during crises while prioritizing long-term strategies for resilience and recovery.

Female Physicians at Higher Risk for Suicide: Key Findings

February 26, 2025 study in JAMA Psychiatry reveals alarming trends in physician suicide rates:

📊 Key Findings

🔹 Female physicians face a significantly higher suicide risk compared to the general U.S. population.
🔹 Male physicians have a lower suicide risk than their nonphysician counterparts.

💡 Why This Matters

These statistics underscore a deeper systemic issue within healthcare
➡️ “Physicians face immense pressure, long hours, and high-stakes decisions, which contribute to burnout and mental health struggles.”

Failure to address these issues can lead to increased physician turnover, lower quality of care, and worsening healthcare outcomes for patients.

✅ What Can Be Done

✔️ Reduce stigma around mental health in medical culture.
✔️ Implement confidential mental health resources specifically for physicians.
✔️ Encourage work-life balance through adjusted schedules and peer support programs.
✔️ Offer routine mental health check-ins as part of employee wellness programs.

📞 Where to Get Help

🆘 If you or someone you know is struggling, help is available:
➡️ Call or text 988 for free, confidential support 24/7.
➡️ Visit the Physician Support Line at www.physiciansupportline.com — available 7 days a week with support from licensed psychiatrists.

💙 It’s time to support those who care for us.

The Dangers of Overpathologizing Behavioral Issues

Psychiatrists could do the profession—and their patients—a great service by resisting the urge to medicalize every behavioral problem, impulsive act, or mood fluctuation as a direct manifestation of psychiatric illness. While genuine psychiatric disorders exist and require careful diagnosis and treatment, many of the struggles patients face are deeply rooted in the complexities of life itself—financial stress, relationship conflicts, loss, trauma, and systemic issues that no DSM diagnosis can fully capture.

When Life Struggles Are Mistaken for Mental Illness

Certain behaviors and emotional responses are frequently overpathologized. For example:

  • A teenager acting out in school following their parents’ divorce may be labeled with oppositional defiant disorder, when their reaction is a predictable response to emotional distress.
  • A grieving spouse who experiences sadness, tearfulness, and withdrawal beyond a few weeks might be diagnosed with major depressive disorder, despite bereavement being a normal and deeply personal process.
  • A person engaging in impulsive spending or risky behaviors after a significant life change might be quickly categorized as having bipolar disorder, when in reality, they are struggling to cope with a sudden transition.

While these behaviors may be distressing, they do not always indicate the presence of a psychiatric disease requiring medication. Instead, they may reflect normal reactions to adversity that should be addressed through support, coping strategies, and time.

The Risks of Overpathologizing Human Experience

The trend of pathologizing problems of living carries significant consequences. Studies have shown that psychiatric overdiagnosis leads to unnecessary medication use, stigma, and a shift in focus away from addressing social determinants of health. For instance, research suggests that antidepressants are prescribed to 1 in 4 U.S. adults, often for mild or situational distress rather than true clinical depression. Moreover, children—particularly boys—are diagnosed with ADHD at disproportionately high rates, sometimes as a response to difficulties in structured classroom settings rather than a true neurodevelopmental disorder.

Overpathologizing also impacts the credibility of psychiatry. If every struggle is framed as a disorder, the public may begin to view psychiatric diagnoses with skepticism, undermining trust in the profession and the legitimacy of serious mental illnesses.

A Case That Stuck With Me

I once treated a young man who had been brought to the hospital by his family after he quit his job, broke up with his girlfriend, and started making impulsive purchases. His parents were convinced he had bipolar disorder, having read online that sudden life changes and spending sprees were signs of mania. However, after spending time with him, it became clear that his actions were rooted in profound dissatisfaction with his life, not a mood disorder. He was struggling with feelings of stagnation, a lack of purpose, and a desire to redefine himself—not symptoms of an illness, but a human experience.

Despite my clinical assessment, his family was frustrated. They wanted a diagnosis, a label, a treatment plan—something concrete. It was difficult for them to accept that not every distressing experience fits neatly into a medical framework.

How Can Psychiatry Do Better?

Psychiatrists and mental health professionals must be intentional in distinguishing true mental illness from the expected emotional and behavioral responses to life’s challenges. Some ways to do this include:

  • A thorough biopsychosocial assessment that considers the role of environmental, cultural, and situational factors in a patient’s presentation.
  • The judicious use of psychiatric diagnoses, ensuring that labels are assigned only when they accurately reflect a disorder rather than a reaction to stress.
  • Education for patients and families about the natural spectrum of human emotions, helping them understand that distress does not always equate to disease.
  • Advocating for systemic solutions, such as better social support networks, financial resources, and access to therapy, so that emotional struggles are not automatically funneled into the medical system.

Addressing the Counterarguments

Some might argue that withholding a diagnosis could prevent patients from accessing the care they need. While it’s true that a psychiatric label can sometimes be a gateway to services and support, misdiagnosis can be just as harmful. Providing the wrong diagnosis can lead to unnecessary medication, reinforce a sense of pathology where none exists, and obscure the real sources of distress. The challenge for psychiatrists is to walk this fine line carefully—validating suffering without automatically medicalizing it.

Conclusion: A Call for Thoughtful Psychiatry

As psychiatrists, our role is not simply to diagnose and medicate, but to thoughtfully assess and guide. True psychiatric illness must be identified and treated appropriately, but we must also be cautious not to medicalize the normal, albeit painful, struggles of life. The goal should always be to help patients find real, meaningful solutions—whether that means therapy, life changes, or, in some cases, just the reassurance that what they are feeling is part of the human experience.

Boost Your Brain Health with Exercise: What the Science Says

If you’re looking for a way to protect and enhance your brain health, regular exercise should be at the top of your list. Decades of randomized controlled trial (RCT) data have consistently shown that moderate to vigorous physical activity is one of the most effective strategies for maintaining cognitive function and reducing the risk of neurological and mental health disorders.

How Exercise Supports Brain Health

Exercise is not just about physical fitness—it has profound effects on brain function and resilience. Research has demonstrated that regular physical activity contributes to:

✅ Reduced Risk of Dementia & Cognitive Decline – Studies indicate that individuals who engage in moderate to vigorous exercise have up to a 30-40% lower risk of developing dementia compared to those with sedentary lifestyles. Physical activity enhances neuroplasticity, promotes new neuron growth (neurogenesis), and improves synaptic function—all crucial factors in preventing cognitive decline.

✅ Improved Stroke Prevention & Recovery – Exercise lowers blood pressure, enhances circulation, and improves endothelial function, significantly reducing the risk of stroke. For stroke survivors, RCTs suggest that physical rehabilitation incorporating aerobic and strength training can improve motor function, cognitive recovery, and quality of life.

✅ Lower Rates of Anxiety & Depression – Multiple RCTs have shown that exercise is as effective as antidepressantsin treating mild to moderate depression, thanks to its ability to regulate neurotransmitters like serotonin, dopamine, and endorphins. Regular physical activity also reduces cortisol (stress hormone) levels, improving resilience to stress and anxiety disorders.

✅ Better Sleep Quality – Exercise plays a crucial role in regulating circadian rhythms and increasing slow-wave (deep) sleep, which is essential for cognitive recovery and emotional processing. RCTs show that individuals with insomnia who engage in aerobic exercise experience significant improvements in sleep latency, duration, and overall sleep quality.

How Much Exercise is Needed for Brain Benefits?

The gold standard for brain health is a combination of aerobic exercise (such as brisk walking, cycling, or swimming) and strength training (such as weightlifting or bodyweight exercises). Research recommends:

📌 150-300 minutes per week of moderate-intensity aerobic exercise OR 75-150 minutes per week of vigorous-intensity exercise 📌 At least two days per week of strength training to preserve muscle mass and support neuroprotective benefits

The Bottom Line

Regular physical activity isn’t just about fitness—it’s one of the most powerful, evidence-based tools for maintaining brain health, preventing cognitive decline, and improving mental well-being. Whether you’re looking to sharpen memory, reduce stress, or protect against neurological disease, making exercise a regular habit is a science-backed investment in your future.

So, lace up your sneakers, get moving, and give your brain the boost it deserves! 🧠💪

🚨 Mania with Mixed Features: The Ultimate Mood Storm 🌪️

Bipolar mania is intense—but when mixed features are present, it’s a whole different beast. Imagine sky-high energy ⚡ + crushing despair 😞 at the same time. That’s mixed mania—one of the most challenging and high-risk mood states in psychiatry.

🔍 What Does It Look Like?

✅ Racing thoughts 🏎️ + Hopelessness 😔
✅ Insomnia for days 🌙 + Feeling exhausted 😴
✅ Irritability 🔥 + Tearfulness 😢
✅ Grandiosity 👑 + Suicidal thoughts 🚨
✅ Restless energy ⚡ + No pleasure in anything ❌

🚑 Why It’s High Risk

Patients with mania + mixed features have:
⚠️ Higher suicide risk than pure mania
⚠️ More agitation & impulsivity
⚠️ Less response to traditional mood stabilizers

🛑 Treatment Challenges

❌ Antidepressants can worsen symptoms
✅ Mood stabilizers (lithium, valproate) & atypical antipsychotics (quetiapine, olanzapine, lurasidone) are key
✅ Careful monitoring is essential

💡 Takeaway: Mixed mania isn’t just “agitated depression” or “irritable mania”—it’s a unique, dangerous mood state that requires urgent intervention. Recognizing it early can save lives.

Have you encountered mixed mania in practice? Let’s discuss! 👇

🔍 Suicide & Psychosis: What We Can Learn from Recent Research

A new study sheds light on suicide risk in patients with psychotic disorders, comparing those with recent-onset schizophrenia or other psychotic disorders to those with longer illness duration. The findings offer critical insights for clinicians and mental health professionals.

🚨 Key Takeaways:

📌 Early Illness = Higher Risk: Patients within the first five years of their illness had higher suicide rates, emphasizing the need for intensive early intervention.

📌 Common Risk Factors: Across both groups, depression, prior suicide attempts, and substance use were major red flags.

📌 Different Patterns: Those with recent-onset psychosis were more likely to have rapid illness progression, while those with longer illness duration often had chronic distress and social isolation before suicide.

📌 Missed Opportunities? Many had recent healthcare encounters before suicide, highlighting potential gaps in risk assessment and intervention.

🛑 What This Means for Us:
🔹 Early-phase psychosis care should prioritize suicide prevention.
🔹 Screening for depression, substance use, and prior attempts is essential.
🔹 More proactive intervention is needed, especially after hospital visits.

This study reinforces what many frontline clinicians already suspect—suicide prevention in psychosis requires urgent, tailored strategies. How can we improve early detection and support for at-risk patients? Let’s discuss. 👇

The Pill Won’t Solve It All 💊🚫

When every problem you face has been treated exclusively by a pill, you start to believe that the answer to all your struggles lies in finding the right one. 🤔💡

With this mindset, you will never be well. 🧠❌

It’s no different than someone searching for the perfect car 🚗 or the dream home 🏡 to fix their life. Sure, it might bring temporary relief, but in the end, it steals your power, leaving your happiness dependent on external factors you can’t control. 🎭🔗

True healing starts when you reclaim your own agency. 💪🔥

📌 CANMAT Guidelines for Depression: 2023 Update

The Canadian Network for Mood and Anxiety Treatments (CANMAT) released updated guidelines in 2023 for the management of Major Depressive Disorder (MDD), reflecting recent advancements in the field.

Key Updates in the 2023 CANMAT Guidelines:

  1. Personalized Care Approach:
    • Emphasis on shared decision-making, considering patient values, preferences, and treatment history to tailor individualized treatment plans.
  2. Updated Treatment Recommendations:
    • Psychological Therapies: Continued endorsement of therapies like Cognitive Behavioral Therapy (CBT) and Interpersonal Therapy (IPT) for mild to moderate depression.
    • Pharmacological Treatments: Introduction of newer antidepressants and updated recommendations based on recent evidence.
    • Neuromodulation: Expanded guidance on treatments such as Transcranial Magnetic Stimulation (TMS)and Electroconvulsive Therapy (ECT), especially for treatment-resistant cases.
  3. Lifestyle and Complementary Interventions:
    • Recognition of the role of exercisenutrition, and sleep in managing depression.
    • Evaluation of complementary and alternative medicine approaches, providing guidance on their efficacy and safety.
  4. Digital Health:
    • Assessment of digital interventions, including online therapy platforms and mobile applications, as supplementary tools in treatment plans.
  5. Management of Inadequate Response:
    • Strategies for addressing partial or non-response to initial treatments, including augmentation and combination therapies.

These updates underscore the importance of a collaborative and individualized approach in managing MDD, integrating the latest evidence to optimize patient outcomes.

For a comprehensive overview, refer to the full publication: 

pubmed.ncbi.nlm.nih.gov

💊 Antidepressants Prescriptions in the U.S. a Balanced Approach? 🤔

Evidence Supporting Overprescription

  1. Prescribing Without Meeting Diagnostic Criteria
    • 2011 study published in Health Affairs found that only 38.4% of patients prescribed antidepressants met criteria for major depressive disorder (MDD), based on the National Ambulatory Medical Care Survey. Many prescriptions were given for milder depressive symptoms or anxiety disorders, suggesting potential overprescription.
    • Subclinical Depression: Some prescriptions were issued for symptoms that did not meet the diagnostic threshold for any psychiatric disorder.
  2. Primary Care Prescribing Patterns
    • Antidepressants are frequently prescribed in primary care settings, where diagnostic accuracy may be lower than in psychiatric settings.
    • 2020 review in JAMA Internal Medicine highlighted that primary care physicians write 79% of antidepressant prescriptions in the U.S., and these are often issued without consultation with a mental health professional.
  3. Off-Label Use
    • 2016 study in JAMA Psychiatry found that 30% of antidepressant prescriptions are for off-label indications like insomnia, chronic pain, or fatigue, despite limited evidence supporting their efficacy for many of these uses.
  4. Prolonged Use
    • Many individuals take antidepressants for extended periods without regular reassessment. A 2019 study in The British Journal of Psychiatry noted that long-term antidepressant use often continues without clear ongoing benefit, raising questions about whether prescriptions are monitored effectively.

Evidence Suggesting Appropriate or Underprescription

  1. Untreated Mental Illness
    • The World Health Organization (WHO) estimates that nearly 50% of individuals with depression in high-income countries, including the U.S., do not receive treatment.
    • 2017 study in JAMA Psychiatry found that many individuals with severe depressive symptoms go untreated, particularly in low-income or minority populations.
  2. Misperceptions of Overprescription
    • 2020 meta-analysis in The Lancet Psychiatry showed that antidepressants are highly effective for moderate-to-severe depression, and their increased use could reflect improved treatment of these conditions rather than overprescription.
    • Increased public awareness of mental health has led to more people seeking care, which may explain higher prescription rates.
  3. Use in Non-Psychiatric Disorders
    • Antidepressants, particularly SSRIs and SNRIs, are evidence-based treatments for anxiety disorders, PTSD, OCD, and some chronic pain conditions. Their prescription for these conditions might be misinterpreted as “overprescription.”

Balancing Perspectives

The evidence suggests a mixed picture:

  • On one hand, antidepressants are sometimes prescribed without meeting diagnostic criteria or for off-label uses with weak supporting evidence.
  • On the other hand, a significant proportion of individuals with moderate-to-severe depression or anxiety remain untreated, indicating possible under prescription in certain populations.

Scientific Consensus

The issue may stem less from overprescription overall and more from suboptimal prescribing practices, including:

  • Prescribing antidepressants where psychotherapy or other treatments might be more appropriate.
  • Inadequate follow-up or reassessment of long-term users.
  • Limited mental health training for primary care providers, who are often the frontline prescribers.

Powered by WordPress.com.

Up ↑